Lilly's retatrutide shows remarkable weight loss in trials but raises concerns with side effects possibly linked to the drug like nausea and kidney stones. Read more here.

One participant lost 22% of her weight in nine months — substantially faster than the rate seen with approved GLP-1 drugs ...

At the end of the day, weight loss options, like any other health-related decisions, are very personal and must be made on a ...

Health plans are lobbying the Trump administration to scrap a proposal dating from the final days of the Biden administration ...

While some orthopedic and spine surgeons are divided on how medications used for weight loss, including Ozempic and Wegovy, will shape the field, it is undeniable that the drugs are playing an ...

Professor Yeo says if the neuronal sensors and brain pathways involved in appetite regulation are better understood, it may ...

The Hong Kong company saw a reduction in body weight across both cohorts with no serious adverse events reported.

Many patients with overweight or obesity discontinue GLP-1 receptor agonist therapy within 1 year, with higher discontinuation rates seen for those without type 2 diabetes.

CardCash.com to Offer Cost-Effective Solutions for High-Demand GLP-1 Medications as Prescription Drug Market Grows SCHAUMBURG, IL / ACCESS ...